戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  polyangiitis, but are absent in microscopic polyangiitis.
2 reatment of eosinophilic granulomatosis with polyangiitis.
3 orbital inflammation, or granulomatosis with polyangiitis.
4 f the PR3 autoantigen in granulomatosis with polyangiitis.
5 toplasmic antibodies) in granulomatosis with polyangiitis.
6 ith diagnosed Wegener disease or microscopic polyangiitis.
7 ce injury in MPO-ANCA-associated microscopic polyangiitis.
8 as Wegener's granulomatosis) and microscopic polyangiitis.
9 ther Wegener's granulomatosis or microscopic polyangiitis.
10 condition a separate entity from microscopic polyangiitis.
11 is as Wegener granulomatosis and microscopic polyangiitis.
12 egener's granulomatosis [WG], 12 microscopic polyangiitis, 16 Churg-Strauss syndrome [CSS]), and anti
13 rolled patients (87 with granulomatosis with polyangiitis, 23 with microscopic polyangiitis, and 5 wi
14 trophil cytoplasm Abs in granulomatosis with polyangiitis, a form of systemic vasculitis.
15 thritis (aHR = 0.22), or Granulomatosis with Polyangiitis (aHR = 0.08).
16 id Arthritis (aHR=0.64), Granulomatosis with Polyangiitis (aHR=0.21), or Systemic Lupus Erythematosus
17 matosis with polyangiitis (GPA), microscopic polyangiitis and eosinophilic GPA (EGPA), are defined ac
18 c autoantibody (ANCA)-associated microscopic polyangiitis and glomerulonephritis (excluding Wegener's
19 lic asthma, eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome.
20                          Granulomatosis with polyangiitis and microscopic polyangiitis are characteri
21 tic distinctions between granulomatosis with polyangiitis and microscopic polyangiitis that are assoc
22 vasculitis and also that granulomatosis with polyangiitis and microscopic polyangiitis were genetical
23 ts of two main diseases, granulomatosis with polyangiitis and microscopic polyangiitis, and remains a
24  resistance in 107 patients with microscopic polyangiitis and necrotizing and crescentic glomerulonep
25 small vessel vasculitis, such as microscopic polyangiitis and Wegener granulomatosis.
26 d AAV (Wegener granulomatosis or microscopic polyangiitis) and were aged 18 to 75 years at diagnosis.
27 tosis with polyangiitis, 23 with microscopic polyangiitis, and 5 with renal-limited ANCA-associated v
28 lomatosis, polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome.
29 's disease, eosinophilic granulomatosis with polyangiitis, and immunoglobulin A (IgA) vasculitis by a
30 ranulomatosis with polyangiitis, microscopic polyangiitis, and pemphigus vulagris.
31 ulomatosis with polyangiitis and microscopic polyangiitis, and remains among the most devastating and
32 orders such as granulomatous or eosinophilic polyangiitis, and sarcoidoisis.
33 ulomatosis with polyangiitis and microscopic polyangiitis are characterised by a necrotising vasculit
34  with Wegener granulomatosis and microscopic polyangiitis are derived by extrapolating from data abou
35 athological hallmarks of granulomatosis with polyangiitis, but are absent in microscopic polyangiitis
36                           Severe microscopic polyangiitis can result in acute respiratory failure and
37 esponses in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome); and matrix metall
38 e of RTX in eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
39             Eosinophilic granulomatosis with polyangiitis (Churg-Strauss, EGPA) is a systemic small-v
40  (MPA), and eosinophilic granulomatosis with polyangiitis (Churg-Strauss; EGPA), also collectively re
41 e including eosinophilic granulomatosis with polyangiitis (EGPA) accounted for 85 subjects (20%) of w
42 tients with eosinophilic granulomatosis with polyangiitis (EGPA) achieved protocol-defined remission.
43 s promoting eosinophilic granulomatosis with polyangiitis (EGPA) are unclear.
44             Eosinophilic granulomatosis with polyangiitis (EGPA) is a disease with marked elevation o
45             Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare anti-neutrophil cytoplasmi
46             Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare inflammatory disease of un
47             Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic vasculitis with a
48             Eosinophilic granulomatosis with polyangiitis (eGPA) is a small-vessel vasculitis where 4
49             Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic vasculitis associated
50             Eosinophilic granulomatosis with polyangiitis (EGPA) is a type of ANCA-related vasculitis
51             Eosinophilic granulomatosis with polyangiitis (EGPA) is a vasculitis characterized by eos
52 rome (HES), eosinophilic granulomatosis with polyangiitis (EGPA), and eosinophilic asthma using a mul
53 s (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA), that share features of pauci-immune
54 s (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA).
55  (GPA), and eosinophilic granulomatosis with polyangiitis (EGPA).
56  (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA).
57 tients with eosinophilic granulomatosis with polyangiitis (EGPA).
58  (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg-Strauss), are a group
59 CA-negative eosinophilic granulomatosis with polyangiitis [EGPA] overlaps).
60 phils from patients with granulomatosis with polyangiitis expressing high membrane PR3 levels showed
61 ing two major syndromes: granulomatosis with polyangiitis (formerly known as Wegener's granulomatosis
62 vation of neutrophils in granulomatosis with polyangiitis (formerly Wegener disease).
63  a 15-year-old girl with granulomatosis with polyangiitis, formerly known as Wegener's granulomatosis
64  scans, 3 patients), and granulomatosis with polyangiitis (GPA) (3 scans, 1 patient).
65 tion with categories for granulomatosis with polyangiitis (GPA) (Wegener's), microscopic polyangiitis
66 mal gland involvement in granulomatosis with polyangiitis (GPA) commonly accompanies orbital disease,
67 Ocular manifestations of granulomatosis with polyangiitis (GPA) have been reported in a limited numbe
68                          Granulomatosis with polyangiitis (GPA) is a potentially fatal small vessel v
69                          Granulomatosis with polyangiitis (GPA) is a rare, aggressive, and rapidly pr
70                          Granulomatosis with polyangiitis (GPA) is a systemic necrotizing vasculitis
71                          Granulomatosis with polyangiitis (GPA) is an antineutrophil cytoplasmic anti
72                          Granulomatosis with polyangiitis (GPA) is an uncommon autoimmune disease inv
73 tions in ANCA-associated granulomatosis with polyangiitis (GPA) may be present, however, severe, life
74                          Granulomatosis with polyangiitis (GPA) represented the highest the percentag
75 opic polyangiitis (MPA), granulomatosis with polyangiitis (GPA), and eosinophilic granulomatosis with
76 t interrelated diseases: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and e
77 sculitis (AAV) comprises granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and e
78  mirroring patients with granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and
79 ee AAV subgroups, namely granulomatosis with polyangiitis (GPA), microscopic polyangiitis and eosinop
80                          Granulomatosis with polyangiitis (GPA), previously Wegener's granulomatosis,
81 c polyangiitis (MPA) and granulomatosis with polyangiitis (GPA), share similarities but differ in cli
82 a specific advantage for granulomatosis with polyangiitis (GPA).
83 aspergillosis (ABPA) and granulomatosis with polyangiitis (GPA).
84 mune vasculitis, such as granulomatosis with polyangiitis (GPA).
85 onfirming a diagnosis of granulomatosis with polyangiitis (GPA).
86 omatous lesions found in granulomatosis with polyangiitis (GPA, formerly Wegener's) or the developmen
87 associated vasculitides, granulomatosis with polyangiitis (GPA, formerly Wegener's), microscopic poly
88  systemic vasculitis and granulomatosis with polyangiitis (GPA, Wegener's granulomatosis).
89         A key feature of granulomatosis with polyangiitis (GPA; or Wegener's granulomatosis) is the g
90    We report the development of eosinophilic polyangiitis granulomatosis (EGPA) in a young girl being
91 ales in the eosinophilic granulomatosis with polyangiitis group (p < .04).
92 al features of kidney disease in microscopic polyangiitis have been associated with clinical presenta
93 condition, most commonly granulomatosis with polyangiitis; however, bilaterality was not associated w
94 monstrates greater similarity to microscopic polyangiitis in relapse rate than previously reported.
95                                  Microscopic polyangiitis is a subgroup of primary systemic vasculiti
96                                  Microscopic polyangiitis is an autoimmune small-vessel vasculitis th
97             Eosinophilic granulomatosis with polyangiitis is an eosinophilic vasculitis.
98                                  Microscopic polyangiitis is defined within the context of primary sy
99 nagement of renal involvement in microscopic polyangiitis is discussed, with emphasis on prognosis an
100 PR3), the autoantigen in granulomatosis with polyangiitis, is expressed at the plasma membrane of res
101 sis, Churg-Strauss syndrome, and microscopic polyangiitis, is impeded by the small number of pediatri
102 ipants with eosinophilic granulomatosis with polyangiitis, mepolizumab resulted in significantly more
103 cludes Wegener's granulomatosis, microscopic polyangiitis (microscopic polyarteritis), the Churg-Stra
104 c lymphocytic leukaemia, granulomatosis with polyangiitis, microscopic polyangiitis, and pemphigus vu
105 y diagnosed or relapsing granulomatosis with polyangiitis, microscopic polyangiitis, or renal-limited
106 matosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with
107 matosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with
108             The main phenotypes, microscopic polyangiitis (MPA) and granulomatosis with polyangiitis
109 tinction between classic PAN and microscopic polyangiitis (MPA) has not always been made.
110 egener's granulomatosis (WG) and microscopic polyangiitis (MPA) have been reported to be pathological
111                                  Microscopic polyangiitis (MPA) may present with a syndrome that rese
112 matosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with
113 iitis (GPA, formerly Wegener's), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with
114 h polyangiitis (Wegener's; GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with
115  polyangiitis (GPA) (Wegener's), microscopic polyangiitis (MPA), and kidney-limited disease; 2) the E
116 rse patterns of injury including microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GP
117 hy include polyarteritis nodosa, microscopic polyangiitis (MPA), rheumatoid vasculitis, Churg-Strauss
118 egener's granulomatosis (WG) and microscopic polyangiitis (MPA).
119 ve patients (64 with WG, 14 with microscopic polyangiitis [MPA], and 526 others) and 45 healthy volun
120                                  Microscopic polyangiitis, MPO-ANCA, higher serum creatinine, crescen
121 creased in patients with granulomatosis with polyangiitis, MVs generated from neutrophils expressing
122 ived a KTX for ESRD secondary to microscopic polyangiitis (n=43) or Wegener's granulomatosis (n=42).
123 oncluded that most patients with microscopic polyangiitis or necrotizing and crescentic glomeruloneph
124 matosis with polyangiitis versus microscopic polyangiitis), or new diagnosis (versus relapsing diseas
125 ranulomatosis with polyangiitis, microscopic polyangiitis, or renal-limited ANCA-associated vasculiti
126 rythematosus (P = 2.7 x 10(-8)), microscopic polyangiitis (P = 2.9 x 10(-4)) and Wegener's granulomat
127 il cytoplasmic antibody-positive microscopic polyangiitis, resulting in pulmonary hemorrhage and acut
128 ommon at high latitudes, whereas microscopic polyangiitis shows the reverse pattern.
129 as rheumatoid arthritis, granulomatosis with polyangiitis, Sjogren's syndrome, sarcoidosis, and infec
130 ulomatosis with polyangiitis and microscopic polyangiitis that are associated with ANCA specificity,
131 ntrolling for age, ANCA pattern, microscopic polyangiitis versus glomerulonephritis alone, and pulmon
132 NCA type, AAV diagnosis (granulomatosis with polyangiitis versus microscopic polyangiitis), or new di
133 s with chronic relapsing granulomatosis with polyangiitis (Wegener's) (GPA).
134 eported in patients with granulomatosis with polyangiitis (Wegener's) (GPA).
135 cluded 180 patients with granulomatosis with polyangiitis (Wegener's) (GPA).
136                          Granulomatosis with polyangiitis (Wegener's) is a rare autoimmune neutrophil
137 esis and presentation of granulomatosis with polyangiitis (Wegener's).
138 b (RTX) in patients with granulomatosis with polyangiitis (Wegener's; GPA), microscopic polyangiitis
139 ulomatosis with polyangiitis and microscopic polyangiitis were genetically distinct.
140 , including 69 with evidence for microscopic polyangiitis, were evaluated for this study.
141 itivity and eosinophilic granulomatosis with polyangiitis, which accounted for 34.1% and 12.8% of cas
142  refractory eosinophilic granulomatosis with polyangiitis who had received treatment for at least 4 w

 
Page Top